Identification of autoimmune type 1 diabetes and multiple organ‐specific autoantibodies in adult‐onset non‐insulin‐requiring diabetes in China: A population‐based multicentre nationwide survey
- 24 November 2018
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 21 (4), 893-902
- https://doi.org/10.1111/dom.13595
Abstract
Aims To investigate the prevalence of adult‐onset autoimmune diabetes (ADM) and predisposition to autoimmune diseases by quantifying serum organ‐specific autoantibodies in people with phenotype of type 2 diabetes (T2D). Materials and methods We included a nationally representative sample of 46 239 adults aged ≥20 years from 14 provinces, of whom 4671 had diabetes, plus 1000 control subjects with normal glucose tolerance (NGT). Participants were screened centrally for autoantibodies to glutamic acid decarboxylase (GAD), islet antigen 2 (IA2) and zinc transporter isoform‐8 (Znt8) and were defined as having ADM where positive for these antibodies. We then assayed thyroid peroxidase (TPO), tissue transglutaminase (tTG) and 21‐hydroxylase (21‐OH) autoantibodies in randomly selected participants with ADM and in age‐matched, sex‐matched and non‐ADM controls with T2D plus controls with NGT. Results Post‐normalization, the standardized prevalence rate of ADM was 6.0% (95% confidence interval [CI] 5.3‐6.8) in initially non‐insulin‐requiring participants with ADM, corresponding to six million adults in China, in whom adjusted antibody positivity was: TPO autoantibodies 16.3% (95% CI 10.8‐21.8), tTG autoantibodies 2.1% (95% CI 0.0‐4.2), and 21‐OH autoantibodies 1.8% (95% CI ‐0.2 to 3.8). Those participants with ADM who were GAD autoantibody‐positive had high risk of TPO autoantibody positivity (odds ratio [OR] 2.39, P = 0.0031) and tTG autoantibody positivity (OR 6.98, P = 0.027), while those positive for IA2 autoantibodies had a high risk of tTG autoantibody positivity (OR 19.05, P = 0.001). Conclusions A proportion of people with phenotype of T2D in China have ADM, with diabetes‐associated autoantibodies, and may be at risk of developing other organ‐specific autoimmune diseases; therefore, it may be clinically relevant to consider screening such Chinese populations.Keywords
Funding Information
- National Natural Science Foundation of China (81461168031)
This publication has 34 references indexed in Scilit:
- Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical PhenotypeDiabetes Care, 2013
- Latent autoimmune diabetes in adults in Asians: Similarities and differences between East and West (亚洲成人隐匿性自身免疫糖尿病的特点:东西方种族差异之比较)Journal of Diabetes, 2013
- Frequency, Immunogenetics, and Clinical Characteristics of Latent Autoimmune Diabetes in China (LADA China Study)Diabetes, 2013
- High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adultsClinical Endocrinology, 2011
- Prevalence of Diabetes among Men and Women in ChinaNew England Journal of Medicine, 2010
- Homozygosity of the Polymorphism MICA5.1 Identifies Extreme Risk of Progression to Overt Adrenal Insufficiency among 21-Hydroxylase Antibody-Positive Patients with Type 1 DiabetesJournal of Clinical Endocrinology & Metabolism, 2009
- Zinc Transporter 8 Antibodies Complement GAD and IA-2 Antibodies in the Identification and Characterization of Adult-Onset Autoimmune DiabetesDiabetes Care, 2009
- High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune DiabetesDiabetes Care, 2007
- Diabetes-related antibodies in adult diabetic patientsBest Practice & Research Clinical Endocrinology & Metabolism, 2005
- One Third of HLA DQ2 Homozygous Patients with Type 1 Diabetes Express Celiac Disease-Associated Transglutaminase AutoantibodiesJournal of Autoimmunity, 1999